BioPharm International eBulletin
Having trouble viewing this e-mail? CLICK HERE

advertisement
BioPharm International
May 5, 2020
WEBSITE CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

TOP STORIES


COVID-19 Update

Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /

Remdesivir Approved for Emergency Use

FDA’s EUA provides the first new treatment for COVID-19 patients with severe symptoms.
/ read more /

 
ADVERTISEMENT

BIO International Convention
Take your business BEYOND expectations at the world's largest biotechnology partnering event! Join over 17,000 biotech and pharma professionals from around the world for four days of BIO One-on-One Partnering, world-class education sessions, and the expansive BIO Exhibition featuring 1,800+ innovative companies.
Learn More »

 
advertisement

Subscribe

Subscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.

subscription offers
subscribe

advertisement

Industry News


New ASTM Standard Addresses Foreign Particles in Biomanufacturing Processes

The ASTM standard describes how to evaluate single-use systems for foreign particle analysis.
/ read more /


INTERPHEX Rescheduled for 2021 Due to COVID-19

The event will be rescheduled for April 20–22, 2021 at the Javits Center in New York City.
/ read more /


MORE INDUSTRY NEWS
 
ADVERTISEMENT

Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »


Biopharma News


AstraZeneca, University of Oxford Collaborate on COVID-19 Vaccine

AstraZeneca and the University of Oxford have announced that they will collaborate on the global development and distribution of the university’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection.
/ read more /


Catalent to Manufacture J&J’s Lead COVID-19 Vaccine Candidate

Catalent and Johnson & Johnson announce joint investment and tech transfer to prepare for rapid scale-up and segregated cGMP commercial manufacturing capacity.
/ read more /


More Biopharma News
 

Supplier News


Protagen Protein Services Expands Capabilities for Aggregate Analytics

The company has expanded capabilities for aggregate analytics to include dynamic light scattering.
/ read more /



UK Biotech Discovers Two Novel Treatments for COVID-19 Patients

ILC Therapeutics, a biotech company based in the United Kingdom, has discovered two separate novel treatments for patients suffering with COVID-19 prior to needing ventilators.
/ read more /


More Supplier News

Regulatory News


Merck & Co.’s Keytruda Approved by FDA for Additional Recommended Dose

The approval was based on pharmacokinetic data, the relationship of exposure to efficacy, and the relationship of exposure to safety.
/ read more /



EMA Endorses Statement Pledging to Fight COVID-19

The statement, published by the International Coalition of Medicines Regulatory Authorities, outlined its commitment to a strengthening of global collaboration in the fight against COVID-19.
/ read more /


More Regulatory News

FEATURED TOPICS

QUALITY SYSTEMS

Critical Knowledge for Preparing Audits

Addressing data integrity, quality culture, aging facilities, investigations/corrective actions and preventive actions, and risk management is key when conducting audits, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
/ read more /

 

OUTSOURCING

Packaging Preserves the Cold Chain

More sustainable and functional packaging protects temperature-sensitive drugs.
/ read more /


PEER-REVIEWED RESEARCH

Therapeutic Potential of Green, Synthesized Gold Nanoparticles

This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.
/ read more /

ANALYTICS

Accepting the Challenge of Protein Characterization

Protein characterization is a critical part of drug development, but as there are still limitations with available techniques, industry needs to look at technological advances to meet the specific requirements of complex molecule characterization.
/ read more /

PRODUCT/SERVICES PROFILE

Integrated Biologics Development Services

Catalent Biologics has the capabilities and experience in the development, manufacturing, and analytical services for new biological entities, cell and gene therapies, biosimilars, and antibody-drug conjugates.
/ read more /

WEBCASTS


Practical Method Development Strategies for the Analysis of Monoclonal Antibodies by Reversed-Phase HPLC
Thursday, May 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Vaccines Illuminated: Biophysical Characterization, PAT, and Quality Control via Light-Scattering Techniques
Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Are You Seeing the Whole Picture? Backgrounded Membrane Imaging (BMI) as a Multi-Use Analytical Tool for Developability Assessment through Late Stage Formulation
Tuesday, May 12, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Accurate Weighing of Reference Standards in a QC Laboratory
Thursday, May 28, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Learn More



Rescheduled Events

CPhI South East Asia

CPhI South East Asia has been rescheduled for July 2020.

69th PDA Annual Meeting

PDA’s Annual Meeting has been rescheduled for July 2020.

Bioprocessing Summit Europe

Bioprocessing Summit Europe has been rescheduled for July 2020.

PDA Pharmaceutical Manufacturing Data Science Workshop

PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.

CPhI North America

CPhI North America has been rescheduled for September 2020.

CPhI Japan

CPhI Japan has been rescheduled for September 2020.

Analytica 2020

Analytica 2020 has been rescheduled for October 2020.

Interpack 2020

Interpack 2020 has been rescheduled for February 2021.

Interphex 2020

Interphex 2020 has been rescheduled for April 2021.

more events

eBook

Regulatory Sourcebook and Reference, March 2020

The Pharmacopoeia Compliance Series features a description of ways biopharma companies can participate in monograph development, a case study of a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise